Study
|
Country
|
Ethnicity
|
Tumors
|
Patients(female/male)
|
Age(range)
|
Result
|
Follow-up (month)
|
Uni\Multi
|
Cutoff value
|
NOS Score
|
---|
Sun et al, 2016 [24]
|
China
|
Asian
|
NC
|
251 (71\180)
|
46 (15-76)
|
OS PFS
|
50 (5-84)
|
Multi
|
2.6
|
8
|
Wong et al, 2015 [25]
|
UK
|
Caucasian
|
LSCC
|
140 (19\121)
|
66 (36-92)
|
OS DFS
|
41 (2-103)
|
Multi
|
3.1
|
8
|
Fu et al, 2016 [26]
|
China
|
Asian
|
LSCC
|
420 (7\413)
|
60 (33-84)
|
OS CSS
|
ungiven
|
Multi
|
2.59
|
7
|
An et al, 2011 [27]
|
China
|
Asian
|
NC
|
363 (89\274)
|
47 (12-76)
|
DSS MFS
|
62 (2-92)
|
Multi
|
3.73
|
7
|
Li et al, 2015 [28]
|
China
|
Asian
|
NC
|
363 (89\274)
|
47 (12-76)
|
DSS
|
14.7 (3.22-92.9)
|
Multi
|
2.81
|
8
|
He et al, 2012 [29]
|
China
|
Asian
|
NC
|
1410 (383\1027)
|
46.1 (13-79)
|
OS PFS
|
41 (2-60)
|
Multi
|
2.74
|
7
|
Fang et al, 2013 [30]
|
China
|
Asian
|
OCSCC
|
226 (19\207)
|
52.47 (27.0-84.0)
|
OS DFS
|
ungiven
|
Uni
|
2.44
|
6
|
Nakahira et al, 2016 [31]
|
Japan
|
Asian
|
NS
|
100 (14\86)
|
65.2 (37-85)
|
CSS
|
37.85 (4-92)
|
Multi
|
3
|
8
|
Perisanidis et al, 2013 [32]
|
Austria
|
Caucasian
|
OCSCC
|
97 (30\67)
|
ungiven
|
DSS
|
> 5 years or until death
|
Multi
|
1.9
|
7
|
Charles et al, 2016 [33]
|
Australia
|
Caucasian
|
HNSCC
|
145 (30\115)
|
63 (23-86)
|
OS RFS
|
29 (1.5-84)
|
Multi
|
5
|
8
|
Tu et al, 2015 [34]
|
China
|
Asian
|
LSCC
|
141 (4\137)
|
59 (36-87)
|
OS DFS
|
51 (5-102)
|
Multi
|
2.17
|
7
|
Moon et al, 2016 [35]
|
Korea
|
Asian
|
HNSCC
|
153 (24\129)
|
57 (16-78)
|
OS PFS CSS
|
39.5 (4.7-62.6)
|
Multi
|
3.3
|
8
|
Rachidi et al, 2016 [36]
|
America
|
Caucasian
|
HNSCC
|
543 (123\420)
|
58.8
|
OS
|
64.4 (2-156)
|
Multi
|
4.39
|
8
|
Song et al, 2015 [37]
|
China
|
Asian
|
HSCC
|
146 (10\136)
|
57.5 (34-89)
|
OS
|
33.2 (2-128)
|
Uni
|
2.3
|
7
|
Salim et al, 2015 [38]
|
Turkey
|
Caucasian
|
HNSCC
|
79 (8\71)
|
59 (28-85)
|
OS
|
ungiven
|
Uni
|
2.93
|
6
|
Haddad et al, 2015 [39]
|
Australia
|
Caucasian
|
HNC
|
46 (8\38)
|
59 (43-81)
|
OS MFS RFS
|
34 (13-47)
|
Uni
|
5
|
5
|
Rassouli et al, 2015 [40]
|
Canada
|
Caucasian
|
HNSCC
|
273 (75\198)
|
64 + _12
|
DFS
|
45 (42-48)
|
Uni
|
4.27
|
6
|
Selzer et al, 2015 [41]
|
Austria
|
Caucasian
|
HNC
|
318 (121\247)
|
ungiven
|
OS
|
ungiven
|
Uni
|
1.58
|
7
|
Kim et al, 2016 [42]
|
Korea
|
Asian
|
HNC
|
104 (9\95)
|
58 (20-82)
|
OS PFS
|
39 (4.8-82.5)
|
Multi
|
3
|
8
|
- NC nasopharyngeal carcinoma, LSCC laryngeal squamous cell carcinoma, OCSCC Oral Cavity Squamous Cell Carcinoma, HNSCC Head and neck squamous cell carcinoma, HSCC hypopharyngeal squamous cell carcinoma, HNC head and neck cancer, Uni univariate analysis, MFS metastasis-free survival, Multi multivariate analysis, NOS score Newcastle-Ottawa Scale score, > 5 meant relative good quality